Alessia Noto

1.8k total citations
18 papers, 936 citations indexed

About

Alessia Noto is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Alessia Noto has authored 18 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Alessia Noto's work include Cancer, Lipids, and Metabolism (5 papers), Cancer Cells and Metastasis (4 papers) and HER2/EGFR in Cancer Research (4 papers). Alessia Noto is often cited by papers focused on Cancer, Lipids, and Metabolism (5 papers), Cancer Cells and Metastasis (4 papers) and HER2/EGFR in Cancer Research (4 papers). Alessia Noto collaborates with scholars based in Italy, United States and Malaysia. Alessia Noto's co-authors include Rita Mancini, Gennaro Ciliberto, Claudia De Vitis, Maria Elena Pisanu, Maria Rosaria Giovagnoli, Alberto Rícci, Luigi Aurisicchio, Giuseppe Roscilli, Maria Rosaria Torrisi and Enrico Giarnieri and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Oncogene.

In The Last Decade

Alessia Noto

18 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessia Noto Italy 17 479 370 289 199 130 18 936
Bolag Altan Japan 19 593 1.2× 308 0.8× 388 1.3× 158 0.8× 99 0.8× 35 1000
Elisabetta Zulato Italy 16 600 1.3× 492 1.3× 342 1.2× 266 1.3× 73 0.6× 37 1.0k
Trudey Nicklee Canada 15 566 1.2× 334 0.9× 739 2.6× 375 1.9× 72 0.6× 20 1.4k
Jiangdong Qiu China 14 580 1.2× 489 1.3× 525 1.8× 150 0.8× 116 0.9× 22 1.2k
Yanwei Shen China 16 636 1.3× 483 1.3× 400 1.4× 199 1.0× 83 0.6× 39 1.2k
John S. Yordy United States 18 788 1.6× 353 1.0× 605 2.1× 346 1.7× 126 1.0× 32 1.5k
Chao‐Nan Qian China 20 932 1.9× 476 1.3× 380 1.3× 447 2.2× 213 1.6× 49 1.5k
Islam M. Miligy United Kingdom 21 435 0.9× 416 1.1× 506 1.8× 103 0.5× 60 0.5× 47 1.0k
Lorna Pope United Kingdom 9 567 1.2× 328 0.9× 338 1.2× 317 1.6× 54 0.4× 15 1.0k
Michael Mueckler United States 7 569 1.2× 274 0.7× 159 0.6× 104 0.5× 152 1.2× 7 912

Countries citing papers authored by Alessia Noto

Since Specialization
Citations

This map shows the geographic impact of Alessia Noto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessia Noto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessia Noto more than expected).

Fields of papers citing papers by Alessia Noto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessia Noto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessia Noto. The network helps show where Alessia Noto may publish in the future.

Co-authorship network of co-authors of Alessia Noto

This figure shows the co-authorship network connecting the top 25 collaborators of Alessia Noto. A scholar is included among the top collaborators of Alessia Noto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessia Noto. Alessia Noto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mancini, Rita, Alessia Noto, Maria Elena Pisanu, et al.. (2018). Metabolic features of cancer stem cells: the emerging role of lipid metabolism. Oncogene. 37(18). 2367–2378. 110 indexed citations
2.
Pisanu, Maria Elena, Alessia Noto, Claudia De Vitis, et al.. (2017). Blockade of Stearoyl-CoA-desaturase 1 activity reverts resistance to cisplatin in lung cancer stem cells. Cancer Letters. 406. 93–104. 101 indexed citations
3.
Roscilli, Giuseppe, Claudia De Vitis, Fabiana Fosca Ferrara, et al.. (2016). Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity. Journal of Translational Medicine. 14(1). 61–61. 40 indexed citations
4.
Ciardiello, Chiara, Maria Serena Roca, Alessia Noto, et al.. (2016). Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression. Oncotarget. 7(15). 19559–19574. 17 indexed citations
5.
Cherubini, E., Arianna Di Napoli, Alessia Noto, et al.. (2015). Genetic and Functional Analysis of Polymorphisms in the Human Dopamine Receptor and Transporter Genes in Small Cell Lung Cancer. Journal of Cellular Physiology. 231(2). 345–356. 16 indexed citations
6.
Fattore, Luigi, Debora Malpicci, Emanuele Marra, et al.. (2015). Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma. Oncotarget. 6(28). 24823–24841. 25 indexed citations
7.
Fattore, Luigi, Emanuele Marra, Maria Elena Pisanu, et al.. (2014). Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition. Journal of Translational Medicine. 12(Suppl 1). O2–O2. 6 indexed citations
8.
Pisanu, Maria Elena, Alessia Noto, Claudia De Vitis, et al.. (2014). Lung Cancer Stem Cell Lose Their Stemness Default State after Exposure to Microgravity. BioMed Research International. 2014. 1–8. 52 indexed citations
9.
Noto, Alessia, Salvatore Raffa, Claudia De Vitis, et al.. (2013). Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells. Cell Death and Disease. 4(12). e947–e947. 130 indexed citations
10.
Fattore, Luigi, Emanuele Marra, Maria Elena Pisanu, et al.. (2013). Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies. Journal of Translational Medicine. 11(1). 180–180. 56 indexed citations
11.
Rícci, Alberto, Claudia De Vitis, Alessia Noto, et al.. (2013). TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung. Cell Cycle. 12(11). 1696–1703. 32 indexed citations
12.
Noto, Alessia, Claudia De Vitis, Giuseppe Roscilli, et al.. (2013). Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer. Oncotarget. 4(8). 1253–1265. 37 indexed citations
13.
Giarnieri, Enrico, Claudia De Vitis, Alessia Noto, et al.. (2012). EMT markers in lung adenocarcinoma pleural effusion spheroid cells. Journal of Cellular Physiology. 228(8). 1720–1726. 27 indexed citations
14.
Mangino, Giorgio, Zulema Percario, Gianna Fiorucci, et al.. (2011). HIV-1 Nef Induces Proinflammatory State in Macrophages through Its Acidic Cluster Domain: Involvement of TNF Alpha Receptor Associated Factor 2. PLoS ONE. 6(8). e22982–e22982. 37 indexed citations
15.
Aurisicchio, Luigi, Emanuele Marra, Laura Luberto, et al.. (2011). Novel anti‐ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors. Journal of Cellular Physiology. 227(10). 3381–3388. 31 indexed citations
16.
Bruno, Pierdonato, Salvatore Mariotta, Alberto Rícci, et al.. (2011). Reliability of direct sequencing of EGFR: comparison between cytological and histological samples from the same patient.. PubMed. 31(12). 4207–10. 21 indexed citations
17.
Bottomley, Matthew J., Agostino Cirillo, Laura Orsatti, et al.. (2008). Structural and Biochemical Characterization of the Wild Type PCSK9-EGF(AB) Complex and Natural Familial Hypercholesterolemia Mutants. Journal of Biological Chemistry. 284(2). 1313–1323. 107 indexed citations
18.
Noto, Alessia, et al.. (1994). Tumor-associated angiogenesis in prostate cancer.. PubMed. 13(6B). 2377–81. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bolag Altan Breakdown of academic impact, for papers by Elisabetta Zulato Breakdown of academic impact, for papers by Trudey Nicklee Breakdown of academic impact, for papers by Jiangdong Qiu Breakdown of academic impact, for papers by Yanwei Shen Breakdown of academic impact, for papers by John S. Yordy Breakdown of academic impact, for papers by Chao‐Nan Qian Breakdown of academic impact, for papers by Islam M. Miligy Breakdown of academic impact, for papers by Lorna Pope Breakdown of academic impact, for papers by Michael Mueckler
Rankless by CCL
2026